Search - tctmd.com

Displaying 781 - 800 of 943

Sort: Relevancy | Date

Presentation TVT 2016

STATE-OF-THE-ART LECTURE: Balloon Aortic Valvuloplasty in 2016 Equipment, Optimal Procedural Techniques, and Clinical Outcomes

Presenter: Helene Eltchaninoff

June 17, 2016

Presentation TVT 2016

Clinical Decisions in Patients With Low-Gradient AS

Presenter: Allan Schwartz

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

Presentation TVT 2016

Clinical Evidence to Date: Direct and Indirect Annuloplasty

Presenter: Francesco Maisano

June 16, 2016

Presentation TVT 2016

One Clip, Two Clip, More Clips: How to Guide the Decision

Presenter: Paul A. Grayburn

June 16, 2016

Presentation TVT 2016

Clinical Evidence Synthesis: MitraClip in FMR and DMR

Presenter: Anita Asgar

June 16, 2016

Presentation TVT 2016

Study Design for the PARTNER 3 Low-Risk Trial

Presenter: Martin B. Leon

June 16, 2016

Presentation TVT 2016

Study Design for the EVOLUT R Low-Risk Trial

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Updates From the UK All-Comer TAVR Study

Presenter: Neil E. Moat

June 16, 2016

Presentation TVT 2016

Updates From SURTAVI in Intermediate-Risk Patients

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Presenter: Vinod H. Thourani

June 16, 2016

Presentation TVT 2016

Updates From NOTION: The First All-Comer TAVR Trial

Presenter: Lars Sondergaard

June 16, 2016

Presentation TVT 2016

Highlights From PARTNER 2A in Intermediate-Risk Patients

Presenter: Michael J. Mack

June 16, 2016

Presentation TVT 2016

The Current Practice of Risk Profiling and Patient Selection for TAVR in the EU: Evidence Based or Common Sense?

Presenter: Antonio Colombo

June 16, 2016

Presentation TVT 2016

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Thomas Walther

June 16, 2016

Presentation TVT 2016

State-of-the-Art Approach to Reducing Conduction Abnormalities and PVR During TAVR

Presenter: Bernard Prendergast

June 16, 2016

Presentation TVT 2016

The PORTICO TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Ganesh Manoharan

June 16, 2016

Presentation TVT 2016

Imaging Preferences and Hemodynamic Assessments to Determine the Severity of PVR During TAVR: Factors Influencing Treatment Thresholds

Presenter: Didier Tchetche

June 16, 2016

Presentation TVT 2016

TVT 1162: Calcium and the Rising EDP TAVR and Same-Setting PVL Closure

Presenter: Jonathon M. White

June 16, 2016

Advertisement

STATE-OF-THE-ART LECTURE: Balloon Aortic Valvuloplasty in 2016 Equipment, Optimal Procedural Techniques, and Clinical Outcomes

Clinical Decisions in Patients With Low-Gradient AS

What TAVR Needs Next . . . and What It’s Getting

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Clinical Evidence to Date: Direct and Indirect Annuloplasty

One Clip, Two Clip, More Clips: How to Guide the Decision

Clinical Evidence Synthesis: MitraClip in FMR and DMR

Study Design for the PARTNER 3 Low-Risk Trial

Study Design for the EVOLUT R Low-Risk Trial

Updates From the UK All-Comer TAVR Study

Updates From SURTAVI in Intermediate-Risk Patients

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Updates From NOTION: The First All-Comer TAVR Trial

Highlights From PARTNER 2A in Intermediate-Risk Patients

The Current Practice of Risk Profiling and Patient Selection for TAVR in the EU: Evidence Based or Common Sense?

The ACURATE TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

State-of-the-Art Approach to Reducing Conduction Abnormalities and PVR During TAVR

The PORTICO TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Imaging Preferences and Hemodynamic Assessments to Determine the Severity of PVR During TAVR: Factors Influencing Treatment Thresholds

TVT 1162: Calcium and the Rising EDP TAVR and Same-Setting PVL Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content